| Literature DB >> 35038650 |
Abouzar Najafi1, Hossein Daghigh-Kia2, Mahdieh Mehdipour2, Hossein Mohammadi3, Hamed Hamishehkar4.
Abstract
Antioxidant nanoparticles include the potential for improving sperm cryopreservation. The aim of performing this study was to evaluate the effects of gamma-oryzanol (GO) at 0 (C) (control group), 20 (GO20), 40 (GO40), 60 (GO60), 80 (GO80), and 100 (GO100) µM and gamma-oryzanol nanoparticles (GON) at 0 (CN), 20 (GON20), 40 (GON40), 60 (GO60), 80 (GON80), and 100 (GON100) µM on post-thawed sperm quality and fertility of rooster sperm. Sperm motility, plasma membrane integrity, total abnormality, mitochondrial activity (Rhodamine 123), apoptotic features (Annexin V/Propidium iodide), reactive oxygen species (ROS) production, ATP content and the fertility and hatchability were evaluated after thawing. Total motility in GON60 and GON80 were significantly higher compared to control groups (C and CN). GON80 showed the greatest percentages of progressive motilities. When GO80, GON60, and GON80 were added to the cryopreservation medium, the plasma membrane functionality of the semen samples improved. The minimum abnormality of spermatozoa is observed in the group treated with GON80. The groups treated with GON60 and GON80 had greater (P < 0.05) mitochondrial activity. The level of sperm ROS after cryopreservation was significantly lower in GON60 and GON80 groups. Live sperm was significantly higher (P < 0.05) in GON60 and GON80 group compared to other groups. GON60 and GON80 groups also led to the lowest significant percentage of apoptosis-like change sperm. Greater fertility percentages were observed (P < 0.05) when sperm were stored in extenders treated with GON60 and GON80. GON80 resulted in significantly improved hatched eggs compared to C, GO60, GO180 and CN. In conclusion, supplementation of Lake extender with 60 and 80 µM gamma-oryzanol nanoparticles could be a proper process to improve freeze-thawing rooster sperm quality leading to better freeze/thaw characteristics.Entities:
Keywords: cryopreservation; gamma-oryzanol; nanoparticles; rooster; sperm
Mesh:
Substances:
Year: 2021 PMID: 35038650 PMCID: PMC8762470 DOI: 10.1016/j.psj.2021.101637
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 4.014
Effect of different levels of gamma-oryzanol and gamma-oryzanol nanoparticles on motility parameters of rooster sperm assessed by CASA after freeze-thawing.
| Treatments | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameters | C | GO20 | GO40 | GO60 | GO80 | GO100 | CN | GO20N | GON40 | GON60 | GON80 | GON100 | SEM |
| TM (%) | 37.3e | 40.9de | 43.5de | 52.4c | 60.2b | 39.5e | 38.6e | 43.2de | 47.8cd | 66.3ab | 71.7a | 41.8de | 1.59 |
| PM (%) | 16.9d | 17.3cd | 18.2cd | 18.5cd | 22.4bc | 17.2cd | 17.0d | 18.1cd | 19.1cd | 26.8b | 34.9a | 17.3cd | 1.14 |
| VAP (µm/s) | 30.5c | 30.7c | 31.1c | 31.8c | 33.1bc | 30.3c | 30.1c | 30.9c | 32.6bc | 36.3ab | 38.2a | 30.1c | 0.88 |
| VSL (µm/s) | 16.8c | 17bc | 17.4bc | 18.3bc | 19.1abc | 16.9c | 16.9c | 17.3bc | 18.6bc | 20.9ab | 22.8a | 16.9c | 0.83 |
| VCL (µm/s) | 54.2b | 54.4b | 55.2ab | 56.1ab | 57.6ab | 54.3b | 54.3b | 54.8b | 56.9ab | 57.5ab | 60.3a | 54.8b | 1.14 |
| LIN (%) | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | 1.47 |
| STR (%) | 55.4 | 56.1 | 56.3 | 57.7 | 58 | 56 | 56.5 | 56.4 | 57.1 | 58.2 | 59.6 | 56.1 | 3.1 |
| BCF (Hz) | 16.2 | 16.4 | 16.7 | 16.9 | 17.1 | 16.4 | 16.3 | 16.8 | 17 | 17.7 | 18.4 | 16.5 | 0.94 |
| ALH (µm) | 5.5 | 5.3 | 5.1 | 5 | 4.6 | 5.2 | 5.4 | 5.1 | 4.8 | 4.5 | 4.3 | 5.1 | 0.31 |
Abbreviations: LIN, linearity; PM, progressive motility; TM, total motility; VAP, average path velocity; VCL, curvilinear velocity; VSL, straight-line velocity.
Lake extender including gamma-oryzanol (GO) at 0 (C) (control group), 20 (GO20), 40 (GO40), 60 (GO60), 80 (GO80), and 100 (GO100) µM and gamma-oryzanol nanoparticles (GON) at 0 (CN), 20 (GON20), 40 (GON40), 60 (GO60), 80 (GON80), and 100 (GON100) µM.
Different superscripts within the same row indicate significant differences among groups (P < 0.05).
Effect of different levels of gamma-oryzanol and gamma-oryzanol nanoparticles on plasma membrane functionality and abnormal forms of rooster thawed semen.
| Treatments | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameters | C | GO20 | GO40 | GO60 | GO80 | GO100 | CN | GO20N | GON40 | GON60 | GON80 | GON100 | SEM |
| Plasma membrane functionality (%) | 35.8d | 37.4d | 39.1d | 47.5c | 58.4ab | 36d | 36.5d | 41.2cd | 46.1c | 63.2ab | 69.7a | 39.1d | 1.32 |
| Abnormal forms (%) | 17.4a | 17ab | 16.7ab | 16.3ab | 15.6ab | 16.9ab | 17.3ab | 16.5ab | 15.9ab | 12.8ab | 11.5b | 16.5ab | 1.21 |
| Mitochondria activity (%) | 34.9e | 38.8de | 41.1cde | 43.7dc | 56b | 35.2e | 35.1e | 40.9cde | 45.9c | 62.1ab | 65.6a | 35.8e | 1.44 |
| ROS (103 cpm/106 sperm) | 4.1a | 4.1a | 4a | 3.6ab | 2.9bc | 4a | 4.1a | 3.8a | 3.7a | 2.8c | 2.6c | 3.8a | 0.14 |
| ATP (pmol/106 sperm) | 88.7e | 91de | 94.8cde | 102.7bcd | 105abc | 89.5e | 89.3e | 92.9cde | 95.8cde | 110.6ab | 117.2a | 90.5de | 2.69 |
Lake extender including gamma-oryzanol (GO) at 0 (C) (control group), 20 (GO20), 40 (GO40), 60 (GO60), 80 (GO80), and 100 (GO100) µM and gamma-oryzanol nanoparticles (GON) at 0 (CN), 20 (GON20), 40 (GON40), 60 (GO60), 80 (GON80), and 100 (GON100) µM.
Different superscripts within the same row indicate significant differences among groups (P < 0.05).
Effect of different levels of gamma-oryzanol and gamma-oryzanol nanoparticles on live, apoptotic and dead spermatozoa in rooster thawed semen, as assessed by flow cytometry.
| Treatments | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameters | C | GO20 | GO40 | GO60 | GO80 | GO100 | CN | GO20N | GON40 | GON60 | GON80 | GON100 | SEM |
| Live (%) | 37.3e | 38.5e | 40.7de | 48.1c | 56.5b | 37.9e | 37.4e | 41.9cde | 45.8cd | 62.3ab | 65.7a | 38.1e | 1.31 |
| Apoptotic (%) | 24.7a | 23.9a | 22.8a | 21.3ab | 16.6bc | 23.1a | 24.1a | 23.2a | 21.7ab | 13c | 12c | 23.3a | 1.22 |
| Dead (%) | 37.9a | 37.5a | 36.3a | 30.5abcd | 26.8bcd | 38.9a | 38.4a | 34.8ab | 32.3abc | 24.6cd | 22.2d | 38.5a | 1.88 |
Viable (%, AnnexinV−/PI−)), apoptotic (%, AnnexinV+/PI−)) and dead (%, PI+) parameters were analyzed. Lake extender including gamma-oryzanol (GO) at 0 (C) (control group), 20 (GO20), 40 (GO40), 60 (GO60), 80 (GO80), and 100 (GO100) µM and gamma-oryzanol nanoparticles (GON) at 0 (CN), 20 (GON20), 40 (GON40), 60 (GO60), 80 (GON80), and 100 (GON100) µM.
Different superscripts within the same row indicate significant differences among groups (P < 0.05). Different superscripts within the same row indicate differences among groups (P < 0.05).
Effect of gamma-oryzanol and gamma-oryzanol nanoparticles on fertility and hatchability rates of rooster semen after freeze-thawing.
| Parameters | |||
|---|---|---|---|
| Treatments | Fertilized eggs | Hatched eggs | Hatched eggs ratio (hatched/fertilized, %) |
| C | 79 (39.5)c | 46 (23)d | 58.2b |
| GO60 | 110 (55)b | 74 (37)c | 67.2ab |
| GO80 | 117 (58.5)b | 80 (40)bc | 68.3ab |
| CN | 80 (40)c | 47 (23.5)d | 58.7b |
| GON60 | 137 (68.5)a | 98 (49)ab | 71.5a |
| GON80 | 142 (71)a | 105 (52.5)a | 73.9a |
Different superscripts letters within row are significantly different (P < 0.05).
Each experimental group contained 200 eggs initially. Numbers are absolute counts of eggs, with percentages (ratio respect to the initial egg count) between parentheses, except for the hatched eggs ratio.